These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27277775)

  • 21. Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.
    Shiozawa K; Watanabe M; Ikehara T; Yamamoto S; Matsui T; Saigusa Y; Igarashi Y; Maetani I
    World J Hepatol; 2018 Jan; 10(1):95-104. PubMed ID: 29399283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching.
    Golfieri R; Bezzi M; Verset G; Fucilli F; Mosconi C; Cappelli A; Paccapelo A; Lucatelli P; Magand N; Rode A; De Baere T
    Liver Cancer; 2021 Sep; 10(5):522-534. PubMed ID: 34721513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal variations in stump pressure and assessment of images obtained from cone-beam computed tomography during balloon-occluded transarterial chemoembolization.
    Kakuta A; Shibutani K; Ono S; Miura H; Tsushima F; Kakehata S; Basaki K; Fujita H; Seino H; Fujita T; Takai Y
    Hepatol Res; 2016 Mar; 46(5):468-76. PubMed ID: 26333025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed Tomography Perfusion Following Transarterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study in the Early Period.
    Wimmer T; Steiner J; Talakic E; Stauber R; Quehenberger F; Portugaller RH; Schoellnast H
    J Comput Assist Tomogr; 2017; 41(5):708-712. PubMed ID: 28296685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.
    Uller W; Wiggermann P; Gössmann H; Klebl F; Salzberger B; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):55-66. PubMed ID: 22214678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
    Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
    Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter arterial chemoembolization of hepatocellular carcinoma with hepatic arteriovenous shunt after temporary balloon occlusion of hepatic vein.
    Lee JH; Won JH; Park SI; Won JY; Lee DY; Kang BC
    J Vasc Interv Radiol; 2007 Mar; 18(3):377-82. PubMed ID: 17377183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma.
    Arai H; Abe T; Takayama H; Toyoda M; Ueno T; Kakizaki S; Sato K
    Hepatol Res; 2015 Jun; 45(6):663-6. PubMed ID: 25132539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques.
    Imai N; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Hirooka Y; Goto H
    World J Hepatol; 2014 Dec; 6(12):844-50. PubMed ID: 25544871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT.
    Salvaggio G; Campisi A; Lo Greco V; Cannella I; Meloni MF; Caruso G
    Abdom Imaging; 2010 Aug; 35(4):447-53. PubMed ID: 19562414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Hepatocellular Carcinoma Transarterial Chemoembolization using Quantitative Analysis of 2D and 3D Real-time Contrast Enhanced Ultrasound.
    Nam K; Stanczak M; Lyshchik A; Machado P; Kono Y; Forsberg F; Shaw CM; Eisenbrey JR
    Biomed Phys Eng Express; 2018 May; 4(3):035039. PubMed ID: 29887989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model.
    Qian J; Oppermann E; Tran A; Imlau U; Qian K; Vogl TJ
    World J Gastroenterol; 2016 Jun; 22(21):5042-9. PubMed ID: 27275096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
    BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Model for Simulating Drug Delivery during Balloon-Occluded Transarterial Chemoembolization.
    Aramburu J; Antón R; Fukamizu J; Nozawa D; Takahashi M; Ozaki K; Ramos JC; Sangro B; Bilbao JI; Tomita K; Matsumoto T; Hasebe T
    Biology (Basel); 2021 Dec; 10(12):. PubMed ID: 34943256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Numerical zero-dimensional hepatic artery hemodynamics model for balloon-occluded transarterial chemoembolization.
    Aramburu J; Antón R; Rivas A; Ramos JC; Larraona GS; Sangro B; Bilbao JI
    Int J Numer Method Biomed Eng; 2018 Jul; 34(7):e2983. PubMed ID: 29575739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.
    Chen CS; Li FK; Guo CY; Xiao JC; Hu HT; Cheng HT; Zheng L; Zong DW; Ma JL; Jiang L; Li HL
    Oncotarget; 2016 Feb; 7(6):7241-52. PubMed ID: 26769845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules.
    Kawamura Y; Ikeda K; Fujiyama S; Hosaka T; Kobayashi M; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Hepatol Res; 2017 Mar; 47(4):338-346. PubMed ID: 27249401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future.
    Woo HY; Heo J
    Clin Mol Hepatol; 2015 Dec; 21(4):344-8. PubMed ID: 26770921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.